Report ID: UCMIG35A2895
Report ID:
UCMIG35A2895 |
Region:
Global |
Published Date: Upcoming |
Pages:
165
| Tables: 55 | Figures: 60
Global Autoinjectors Market size was valued at USD 7.16 billion in 2022 and is poised to grow from USD 8.37 billion in 2023 to USD 24.59 billion by 2031, growing at a CAGR of 14.42% during the forecast period (2024-2031). Additionally, the autoinjector finished formulations market is anticipated to experience remarkable growth, expected to reach USD 136.5 billion by 2028, up from USD 59.6 billion in 2023, at an impressive CAGR of 18.0%. Autoinjectors are particularly advantageous in medical emergencies due to their ease of administration by caregivers, family members, or the patients themselves.
This report is being written to illustrate the market opportunity by region and by segments, indicating opportunity areas for the vendors to tap upon. To estimate the opportunity, it was very important to understand the current market scenario and the way it will grow in future.
Production and consumption patterns are being carefully compared to forecast the market. Other factors considered to forecast the market are the growth of the adjacent market, revenue growth of the key market vendors, scenario-based analysis, and market segment growth.
The market size was determined by estimating the market through a top-down and bottom-up approach, which was further validated with industry interviews. Considering the nature of the market we derived the Health Care Equipment by segment aggregation, the contribution of the Health Care Equipment in Health Care Equipment & Services and vendor share.
To determine the growth of the market factors such as drivers, trends, restraints, and opportunities were identified, and the impact of these factors was analyzed to determine the market growth. To understand the market growth in detail, we have analyzed the year-on-year growth of the market. Also, historic growth rates were compared to determine growth patterns.
Our industry expert will work with you to provide you with customized data in a short amount of time.
REQUEST FREE CUSTOMIZATIONThe market for Autoinjectors was estimated to be valued at US$ XX Mn in 2021.
The Autoinjectors Market is estimated to grow at a CAGR of XX% by 2028.
The Autoinjectors Market is segmented on the basis of Usage, Technology, Route of Administration, Type, Region.
Based on region, the Autoinjectors Market is segmented into North America, Europe, Asia Pacific, Middle East & Africa and Latin America.
The key players operating in the Autoinjectors Market are Becton, Dickinson and Company (BD), Ypsomed Holding AG , SHL Medical, West Pharmaceutical Services, Inc. , Recipharm AB , Haselmeier GmbH, Owen Mumford Ltd., Gerreshiemer AG , Philip-Medisize, LLC , Oval Medical Technologies Ltd., Solteam Incorporation Co., Ltd., Elcam Drug Delivery Devices (E3D), Antares Pharma, Inc., Jabil, Inc., AbbVie Inc., Amgen Inc., Eli Lilly and Company, Novartis AG , Merck KGaA , Viatris Inc. , Biogen.
Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Report ID: UCMIG35A2895